Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Ventilatory Modes01:14

Ventilatory Modes

Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Elevation of red blood cell distribution width to hematocrit ratio is associated with increased 28-day all-cause mortality in septic patients].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University·2026
Same author

Expert Consensus on the Combined Application of Radiotherapy and Novel Systemic Agents in Breast Cancer Treatment.

Journal of evidence-based medicine·2026
Same author

Development and validation of a multidimensional nomogram for predicting 28-day mortality in sepsis patients with acute lung injury.

Respiratory medicine·2026
Same author

Impaired BCAA catabolism in macrophages exacerbates sepsis-induced lung injury by modulating mitochondrial AGE-RAGE and mtDNA release.

Free radical biology & medicine·2026
Same author

Severe hypercapnia and hemodynamic instability following a sudden elevation in end-tidal CO₂ during thoraco-laparoscopic esophagectomy: a case report and literature review.

BMC cardiovascular disorders·2026
Same author

Pathological Mechanism-Inspired Biomimetic Nano-Senotherapy for Reversing Experimental Atherosclerosis in ApoE<sup>-/-</sup> Mice.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: Jul 3, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Advanced Multiscale Inhalation Platforms for Treatment of Pulmonary Diseases.

Siyu Zhou1, Shasha Ran1, Fang Zhang1

  • 1College of Pharmacy and Food, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu, People's Republic of China.

International Journal of Nanomedicine
|July 2, 2026
PubMed
Summary

Novel inhaled preparations offer improved treatment for lung diseases like COPD and asthma. These advanced formulations, including nanoparticles and liposomes, promise enhanced drug delivery and reduced side effects compared to traditional methods.

Keywords:
biomimetic platformsinhalation preparationsliposomesmicrospheresnanoparticlespulmonary diseases

More Related Videos

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

Related Experiment Videos

Last Updated: Jul 3, 2026

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide
04:16

Inspiratory Muscle Training as an Adjunct to the Treatment of Weaning Failure in Critically Ill Patients: A Practical Guide

Published on: January 30, 2026

Area of Science:

  • Pulmonary medicine and drug delivery systems.
  • Nanotechnology and biomaterials in pharmaceutical applications.

Background:

  • Pulmonary diseases (COPD, asthma, pneumonia, fibrosis, lung cancer) are major global health concerns.
  • Conventional treatments (oral, injection) have limitations including first-pass effects, low bioavailability, and systemic toxicity.
  • Inhaled drug delivery offers advantages like uniform distribution, rapid onset, and avoidance of hepatic first-pass metabolism.

Purpose of the Study:

  • To review research progress on novel inhaled preparations for treating lung diseases.
  • To explore the development and application of advanced inhaled formulations.
  • To highlight potential for improved lung disease treatment through nanotechnology and biomaterials.

Main Methods:

  • Review of current research on novel inhaled preparations.
  • Focus on formulations such as nanoparticles, liposomes, microspheres, and biomimetic platforms.
  • Analysis of advancements in nanotechnology, biomaterials, and preparation processes.

Main Results:

  • Novel inhaled preparations demonstrate significant potential for treating various pulmonary diseases.
  • These formulations can overcome limitations of traditional administration routes.
  • Advancements facilitate more targeted and effective drug delivery to the lungs.

Conclusions:

  • Novel inhaled preparations represent a promising frontier in pulmonary disease therapeutics.
  • The integration of nanotechnology and biomaterials offers enhanced efficacy and safety.
  • Broad research and application prospects suggest improved treatment options for patients.